6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Latest Press Releases

Time	Headline
38m ago	Epsium Enterprise Limited Files Annual Report on Form 20-F for Fiscal Year 2025
1h ago	Newmark Names Jack Fuchs as President of Global Asset Services and Member of the Executive Committee
1h ago	Stop the Rail Merger Coalition Launches to Oppose Union Pacific-Norfolk Southern Merger
1h ago	NorthEast Community Bancorp, Inc. Reports Results for the Three Months Ended March 31, 2026
1h ago	Better Home Equity Card Powered by Stripe Enables Easy Access to HELOC Funds and Introduces a Modern Access Layer Across the $21.4 Trillion Home Equity Market

About

Jaguar Animal Health Inc (NASDAQ:JAGX) — investor relations, events, news, and company updates on 6ix.

Latest News

Jaguar Health Announces Statistically Significant Results from Effectiveness Trial of Crofelemer (FDA Approved Canalevia-CA1) for Treatment of Chemotherapy-Induced Diarrhea in Dogs

Jaguar Health Announces Acceptance of two Late-Breaking Abstracts for Liquid Oral Crofelemer Treatment of Intestinal Failure in Pediatric Patients at the European Society for Pediatric Gastroenterology, Hepatology & Nutrition (ESPGHAN)

Jaguar Health Reports Approval of All Proposals at April 2026 Special Meeting of Stockholders

Jaguar Health Completes Effectiveness Trial to Support FDA Approved Crofelemer for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs

Jaguar Health Reports 2025 Financials

Financials

Revenue

$11.79 M

Market Cap

$4.97 M

EPS

-2.58

Community Chat

Ask AI